Radiation therapy for primary breast lymphoma in male gynecomastia: a rare case report and review of the literature

Int J Hematol. 2016 Oct;104(4):519-24. doi: 10.1007/s12185-016-2026-y. Epub 2016 May 25.

Abstract

Primary breast lymphoma is a rare type of non-Hodgkin lymphoma and usually affects women, although a few cases have been reported in men. Chemotherapy and radiation therapy, or a combination of both, are frequently administered for treatment of primary breast lymphoma, as local control by surgical resection is poor. No standard therapy has been established, and the optimal radiation dose and irradiation field for male patients are unknown. The present report describes a 75-year-old man with bilateral cirrhosis-induced gynecomastia who was diagnosed with primary breast lymphoma; specifically, diffuse large B-cell lymphoma. Because of his hepatic dysfunction, he was treated with radiation therapy alone. Radiation therapy was followed by eight cycles of rituximab monotherapy. Clinical response was good, with no signs of relapse. Clinicians may benefit from knowledge regarding effective treatment of primary breast lymphoma in male patients, which has been rarely reported owing to the low incidence of this condition. The outcome in the present case may help to establish effective treatment guidelines in similar cases.

Keywords: Gynecomastia; Male breast lymphoma; Primary breast lymphoma; Radiation therapy.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Aged
  • Breast Neoplasms, Male / drug therapy
  • Breast Neoplasms, Male / radiotherapy*
  • Combined Modality Therapy / methods
  • Gynecomastia / complications*
  • Gynecomastia / pathology
  • Humans
  • Lymphoma, Large B-Cell, Diffuse / drug therapy
  • Lymphoma, Large B-Cell, Diffuse / radiotherapy*
  • Male
  • Rituximab / therapeutic use
  • Treatment Outcome

Substances

  • Rituximab